I thought the same thing you did: Two of these PR

I thought the same thing you did:

Quote:

---

Two of these PRs look like they’re for potential suitors, not shareholders.

---

But not sure which two you thought that about. The only one, as a shareholder, that mattered to me was the update on the status of the HIV BLA, although in truth it seemed written to a suitor, as well.
The cancer indication is too far away, as we need some approval, any approval, before then.
The CC PR, well, we all know how those sometimes go, so this is really just for show. Anything real significant would have had its own PR.